$64.2 Million is the total value of FARLEY CAPITAL L.P.'s 12 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 53.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DV | Buy | DEVRY ED GROUP INC | $30,609,000 | +8.4% | 1,715,758 | +5.0% | 47.71% | +19.3% |
| MA | Sell | MASTERCARD INCcl a | $16,687,000 | -7.6% | 189,491 | -0.8% | 26.01% | +1.6% |
| VRX | VALEANT PHARMACEUTICALS INTL | $6,192,000 | -23.4% | 307,458 | 0.0% | 9.65% | -15.8% | |
| GOOG | Sell | ALPHABET INCcap stk cl c | $5,377,000 | -13.0% | 7,769 | -6.4% | 8.38% | -4.3% |
| CTRP | New | CTRIP COM INTL LTD | $1,436,000 | – | 34,850 | +100.0% | 2.24% | – |
| SYMC | Sell | SYMANTEC CORP | $1,235,000 | -21.9% | 60,146 | -30.1% | 1.92% | -14.1% |
| BIDU | New | BAIDU INCspon adr rep a | $751,000 | – | 4,550 | +100.0% | 1.17% | – |
| BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b | $691,000 | -46.3% | 4,773 | -47.4% | 1.08% | -41.0% |
| GOOGL | ALPHABET INCcap stk cl a | $364,000 | -7.6% | 517 | 0.0% | 0.57% | +1.6% | |
| VALEANT PHARMACEUTICALS INTL | $342,000 | -23.5% | 17,000 | 0.0% | 0.53% | -15.8% | ||
| EPAM | New | EPAM SYS INC | $251,000 | – | 3,900 | +100.0% | 0.39% | – |
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $217,000 | +1.9% | 1 | 0.0% | 0.34% | +11.9% | |
| V | Exit | VISA | $0 | – | -3,200 | -100.0% | -0.35% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -1,423 | -100.0% | -0.54% | – |
| Exit | UNION PAC CORP | $0 | – | -30,000 | -100.0% | -3.38% | – | |
| LXFT | Exit | LUXOFT HLDG INC | $0 | – | -55,869 | -100.0% | -4.36% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MASTERCARD INC | 35 | Q3 2023 | 43.3% |
| BERKSHIRE HATHAWAY INC DEL | 35 | Q3 2023 | 2.6% |
| BERKSHIRE HATHAWAY INC DEL | 28 | Q3 2023 | 0.6% |
| ALPHABET INC | 25 | Q3 2023 | 20.9% |
| ALPHABET INC | 25 | Q3 2023 | 1.4% |
| ADTALEM GLOBAL ED INC | 19 | Q3 2023 | 56.8% |
| VALEANT PHARMACEUTICALS INTL | 19 | Q4 2017 | 30.1% |
| DEVRY INC DEL | 16 | Q1 2017 | 58.4% |
| META PLATFORMS INC | 16 | Q3 2023 | 11.7% |
| PRAXAIR INC | 13 | Q4 2017 | 3.6% |
View FARLEY CAPITAL L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LaPorte Bancorp, Inc. | February 14, 2014 | ? | ? |
| Oconee Federal Financial Corp. | February 14, 2014 | ? | ? |
| Sunshine Financial Inc | February 14, 2014 | ? | ? |
| BSB Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
| IF Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
| Jacksonville Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
| Poage Bankshares, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
| SP Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
| West End Indiana Bancshares, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
| OBA Financial Services, Inc.Sold out | February 14, 2012 | 0 | 0.0% |
View FARLEY CAPITAL L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View FARLEY CAPITAL L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.